Author

Daniel Maldonado

University of Wisconsin–Madison

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Brittany Russell· 1 shared Christian M. CapitiniiD· 1 shared Diana Marcela TabimaiD· 1 shared Isabelle Zingler-Hoslet· 1 shared José María AyusoiD· 1 shared Keerthana Shankar· 1 shared Kirstan GimseiD· 1 shared Krishanu SahaiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Brittany Russell

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Virus-free CRISPR knock-in of a chimeric antigen receptor into KLRC1 generates potent GD2-specific natural killer cells

Keerthana Shankar, Isabelle Zingler-Hoslet, Diana Marcela Tabima, Seth R. T. Zima, Lei Shi, Kirstan Gimse, Matthew H. Forsberg, Varun Katta, Sage Z. Davis, Daniel Maldonado, Brittany Russell, Muhammed Murtaza, Shengdar Q. Tsai, José María Ayuso, Christian M. Capitini, Krishanu Saha

This study uses CRISPR to disrupt an inhibitory receptor in NK cells and insert a GD2-targeting CAR, creating potent NK cells against GD2+ melanoma.

Molecular Therapy · Jan 14, 2025Peer-reviewedBioengineering